CYP2E1 P450 levels are increased in patients with NASH because fatty acids and ketone bodies including acetone, which increased in diabetes/ketosis [96], are substrates and inducers of CYP2E1 protein. The gene discussed is CYP2B6; the disease is metabolic dysfunction-associated steatohepatitis.